IQVIA
IQV
#791
Rank
NZ$53.45 B
Marketcap
NZ$320.28
Share price
1.39%
Change (1 day)
25.89%
Change (1 year)

Earnings for IQVIA (IQV)

Earnings in 2026 (TTM): NZ$4.02 Billion

According to IQVIA's latest financial reports the company's current earnings are NZ$16.63 Billion. In 2025 the company made an earning of NZ$3.98 Billion a decrease over its 2024 earnings that were of NZ$4.02 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for IQVIA from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$4.02 B0.83%
2025 NZ$3.98 B-0.81%
2024 NZ$4.02 B9.76%
2023 NZ$3.66 B19.79%
2022 NZ$3.05 B18.36%
2021 NZ$2.58 B90.49%
2020 NZ$1.35 B-1.25%
2019 NZ$1.37 B7.68%
2018 NZ$1.27 B6.61%
2017 NZ$1.19 B11.74%
2016 NZ$1.07 B-2.79%
2015 NZ$1.10 B6.31%
2014 NZ$1.03 B34.96%
2013 NZ$0.76 B11.16%
2012 NZ$0.69 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-NZ$3.72 Million-100.09% Bahamas
NRC Health
NRC
NZ$47.41 M-98.83%๐Ÿ‡บ๐Ÿ‡ธ USA